SureTrader
Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs > Nektar Therapeutics (NKTR)

Bad link... try this one for AMLN [#msg-10433899]

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
SeriousMoney Member Profile
 
Followed By 30
Posts 7,965
Boards Moderated 5
Alias Born 04/05/05
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/24/2017 7:40:33 AM
Lilly and Nektar Therapeutics Announce Alliance to Develop and Commercialize NKTR-358, A Novel Autoimmune Therapy "PR Newswire (US)" - 7/24/2017 7:40:00 AM
Lilly and Nektar Therapeutics Announce Alliance to Develop and Commercialize NKTR-358, A Novel Autoimmune Therapy "PR Newswire (US)" - 7/24/2017 7:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/21/2017 9:21:59 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/20/2017 5:09:47 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/18/2017 8:11:53 AM
Nektar Announces Topline Data from Human Abuse Potential Study for NKTR-181, a First-in-Class Investigational Opioid to Treat... "PR Newswire (US)" - 7/18/2017 8:00:00 AM
Nektar Presents New Preclinical Data for NKTR-358, a First-in-Class Regulatory T Cell Stimulator, at 13th World Congress of I... "PR Newswire (US)" - 7/10/2017 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/28/2017 6:05:55 PM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 6/15/2017 5:25:48 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/15/2017 5:01:41 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/9/2017 6:03:15 PM
Nektar to Webcast Presentation at Jefferies 2017 Global Healthcare Conference in New York City "PR Newswire (US)" - 6/6/2017 4:15:00 PM
Nektar Presents New Clinical Data from Two Studies of NKTR-214, a CD122-Biased Agonist, at 2017 American Society of Clinical ... "PR Newswire (US)" - 6/5/2017 9:00:00 AM
New Research Collaboration between Nektar and Takeda to Explore Combination Cancer Therapy Approaches with NKTR-214, a CD122-... "PR Newswire (US)" - 5/22/2017 9:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/19/2017 4:32:42 PM
Nektar Therapeutics Announces Data Presentations at ASCO 2017 "PR Newswire (US)" - 5/18/2017 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/17/2017 6:03:40 PM
Specialized Disclosure Report (sd) "Edgar (US Regulatory)" - 5/15/2017 5:22:50 PM
Nektar to Webcast Presentation at UBS Global Healthcare Conference 2017 in New York "PR Newswire (US)" - 5/15/2017 4:15:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/10/2017 6:11:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/9/2017 4:34:25 PM
Nektar Therapeutics Reports Financial Results for the First Quarter of 2017 "PR Newswire (US)" - 5/9/2017 4:10:00 PM
Nektar Appoints Brian L. Kotzin, M.D. as Head of Clinical Development for Nektar's Immunology Program "PR Newswire (US)" - 5/3/2017 9:15:00 AM
Nektar to Announce Financial Results for the First Quarter of 2017 on Tuesday, May 9, 2017, After Close of U.S.-Based Financi... "PR Newswire (US)" - 5/2/2017 9:15:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist